2.3800
+0.2400
+(11.21%)
At close: January 31 at 9:55:02 PM GMT+1
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 5 | 5 | 5 | 5 |
| Avg. Estimate | 44.36M | 44.92M | 177.47M | 180.5M |
| Low Estimate | 44.3M | 44.5M | 177.4M | 178.3M |
| High Estimate | 44.5M | 45.6M | 177.6M | 182.09M |
| Year Ago Sales | 44.48M | 44.78M | 175.17M | 177.47M |
| Sales Growth (year/est) | -0.26% | 0.31% | 1.31% | 1.71% |
EPS Trend
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | 0 | 0 | 0 | 0 |
| 30 Days Ago | 0 | 0 | 0 | 0 |
| 60 Days Ago | 0 | 0 | 0 | 0 |
| 90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| 73Q.F | -- | -- | -- | -- |
| S&P 500 | 9.91% | 10.33% | 14.01% | 13.75% |
Upgrades & Downgrades
| Reiterates | Needham: Buy to Buy | 1/17/2025 |
| Maintains | Wells Fargo: Underweight to Underweight | 11/7/2024 |
| Reiterates | Needham: Buy to Buy | 11/7/2024 |
| Reiterates | Needham: Buy to Buy | 8/9/2024 |
| Maintains | Wells Fargo: Underweight to Underweight | 6/21/2024 |
| Reiterates | Needham: Buy to Buy | 5/20/2024 |